These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16322600)

  • 1. Immunosuppression related to collagen-vascular disease or its treatment.
    Hamilton CD
    Proc Am Thorac Soc; 2005; 2(5):456-60. PubMed ID: 16322600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis.
    Mehrad B; Strieter RM; Standiford TJ
    J Immunol; 1999 Feb; 162(3):1633-40. PubMed ID: 9973423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary granulomatous inflammation: From sarcoidosis to tuberculosis.
    Perez RL; Rivera-Marrero CA; Roman J
    Semin Respir Infect; 2003 Mar; 18(1):23-32. PubMed ID: 12652451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis or sarcoidosis: Opposite ends of the same disease spectrum?
    Agrawal R; Kee AR; Ang L; Tun Hang Y; Gupta V; Kon OM; Mitchell D; Zierhut M; Pavesio C
    Tuberculosis (Edinb); 2016 May; 98():21-6. PubMed ID: 27156614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary cryptococcal infection in an untreated patient with sarcoidosis.
    Shijubo N; Fujishima T; Ooashi K; Morita S; Shigehara K; Nakata H; Abe S
    Sarcoidosis; 1995 Mar; 12(1):71-4. PubMed ID: 7617982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-TNF: beneficial or hamful for the lung?].
    Tritar F; Zendah I; Ben M'rad S; Daghfous H
    Tunis Med; 2009 Sep; 87(9):607-9. PubMed ID: 20180383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal infections as a complication of therapy for sarcoidosis.
    Baughman RP; Lower EE
    QJM; 2005 Jun; 98(6):451-6. PubMed ID: 15879444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wegener's granulomatosis.
    Lamprecht P; Gross WL
    Herz; 2004 Feb; 29(1):47-56. PubMed ID: 14968341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans.
    Huffnagle GB; Toews GB; Burdick MD; Boyd MB; McAllister KS; McDonald RA; Kunkel SL; Strieter RM
    J Immunol; 1996 Nov; 157(10):4529-36. PubMed ID: 8906831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary tuberculosis in the compromised host at the point of clinical view].
    Yamagishi F; Sasaki Y; Suzuki K
    Kekkaku; 1993 Sep; 68(9):605-10. PubMed ID: 8230964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
    Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
    Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.
    Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Romanus V; Klareskog L; Feltelius N
    Arthritis Rheum; 2005 Jul; 52(7):1986-92. PubMed ID: 15986370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakdown of pulmonary host defense in the immunocompromised host: cancer chemotherapy.
    Joos L; Tamm M
    Proc Am Thorac Soc; 2005; 2(5):445-8. PubMed ID: 16322598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary infection with Cryptococcus neoformans in the face of underlying sarcoidosis.
    Boyton RJ; Altmann DM; Wright A; Kon OM
    Respiration; 2007; 74(4):462-6. PubMed ID: 16106116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis and other mycobacteria.
    Mault JR; Pomerantz M
    Chest Surg Clin N Am; 1999 Feb; 9(1):227-38, x. PubMed ID: 10079988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoidosis in the aged: review and management.
    Tachibana T; Iwai K; Takemura T
    Curr Opin Pulm Med; 2010 Sep; 16(5):465-71. PubMed ID: 20473168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of sarcoidosis.
    Rosen Y
    Semin Respir Crit Care Med; 2007 Feb; 28(1):36-52. PubMed ID: 17330191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.